Pegylated interferon β-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study - Calabresi, PA; Kieseier, BC; Arnold, DL; Balcer, LJ; Boyko, A; Pelletier, J (Lancet Neurol, 2014)